TP53RK and nephrotic syndrome: A recent in vivo knockdown study of OSGEP and TP53RK led to pathologies in the actin cytoskeleton as well as a reduction in the human podocyte migration rate [7]. These pathological manifestations led to the development of nephrotic syndrome [7].